Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin versus rosuvastatin effects on 25-hydroxyvitamin D in acute myocardial infarction
IRCT20190902044673N1Phase 4Completed
- Sponsor
- Neyshabour University of Medical Sciences
- Start
- Feb 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in myocardial infarction (MI) and acute coronary syndrome (ACS) comparing Atorvastatin arm with Rosuvastatin arm (2 arms). Primary endpoint: 25-hydroxy vitamin D level at 2 weeks. Started Feb 2017; status: completed.
02
Drugs
atorvastatinrosuvastatin
03
Conditions
myocardial infarction (MI)acute coronary syndrome (ACS)
Beyond the preview
Go deeper on IRCT20190902044673N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190902044673N1.